Fielmann

Valuation Analysis

About the Company

Fielmann en bref

Fielmann (FIE.DE) is currently trading at 40,65 € with a market capitalization of 3,0 Md €. The trailing P/E ratio stands at 16.66x, with a forward P/E of 13.98x. The 52-week range spans from 38,75 € to 57,00 €; the current price is 28.7% below the yearly high. Year-over-year revenue growth stands at +1.3%. The net profit margin stands at 8.39%.

💰 Dividende

Fielmann pays an annual dividend of 1,40 € per share, representing a yield of 3.44%. The payout ratio stands at 47.13%.

📊 Avis des analystes

8 analystes évaluent Fielmann (FIE.DE) au consensus : None. L'objectif de cours moyen est de 58,62 €, soit un potentiel de +44.22% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 50,00 € à 68,00 €.

Fielmann : la thèse d'investissement en détail

Fielmann (FIE.DE) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in Germany. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 80.11%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue growth has slowed to just 1.3%, which is below nominal GDP — the business is no longer outgrowing the broader economy.

Valorisation en contexte

At a PEG of 3.2, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here. The EV/EBITDA multiple of 9.4x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The forward P/E of 13.98x is meaningfully below the trailing 16.66x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The dividend yield near 3.44% combined with a payout ratio of 47.13% leaves room for further hikes — a track record of consecutive raises is a strong income signal.
• The analyst consensus price target implies 44.22% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Fielmann?

Compare top-rated brokers — low fees, trusted providers, fully regulated.